We use cookies to personalize our website and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.

Skip to main content

The Jackson Laboratory

Home

Recent Searches

Share this Post

Share on facebook
Share on twitter
Share on linkedin
Share on email

Home
JAX Event Presentations
The first comparative study of different lymphoma targeting ADCs in Humanized Mice - Tibor Schomber - 2024 EU Workshop Series

The first comparative study of different lymphoma targeting ADCs in Humanized Mice - Tibor Schomber - 2024 EU Workshop Series

Published Date May 23, 2024

Previous Flipbook

Use of Humanized Mouse Models in Drug Development - Brian Soper - 2024 EU Workshop Series
Next Flipbook

Application of Humanized Mice for Therapeutic Target Validation - Ali Roghenian - 2024 EU Workshop Series

Most Recent Flipbooks

5 months ago
JAX and Authera Focus on FcRn biology - Simone Mester - 2024 EU Workshop Series

Read Flipbook
5 months ago
A Novel PBMC Humanized Mouse - James Keck - 2024 EU Workshop Series

Read Flipbook
5 months ago
Use of Humanized Mouse Models in Drug Development - Brian Soper - 2024 EU Workshop Series

Read Flipbook
5 months ago
Application of Humanized Mice for Therapeutic Target Validation - Ali Roghenian - 2024 EU Workshop Series

Read Flipbook
over 1 year ago
HuPK Highlights for EU Symposium

Read Flipbook
over 1 year ago
Humanized Mice Highlights for EU Symposium

Read Flipbook
over 1 year ago
CRS Highlights for EU Symposium

Read Flipbook
over 1 year ago
Using the Hu-PK Platform to Predict the PK of Candidate Therapeutic Antibodies

Read Flipbook
over 1 year ago
Innovative Humanized In Vivo Models to Evaluate Iatrogenic Cytokine Release Syndrome

Read Flipbook
over 1 year ago
How to Use Humanized Models to Test the Efficacy of Immunotherapies

Read Flipbook
almost 2 years ago
In vivo Preclinical Efficacy & Safety of CAR-T, -NK, and -Myeloid Based Therapies

Read Flipbook
almost 2 years ago
Evaluation of Safety and Efficacy of Antibody-based and CAR T Therapies in PBMC Humanized Mice

Presented by Jiwon Yang, Ph.D. - Senior Scientist, Innovation and Product Development, The Jackson Laboratory

Read Flipbook
almost 2 years ago
Preclinical Assessment of Engineered Immunoglobulins in Immune Humanized Mice

Presented by Brian Soper, Ph.D. - Senior Scientific Engagement Manager, The Jackson Laboratory

Read Flipbook
almost 2 years ago
Modeling Therapeutic Antibody Pharmacokinetics in Human FcRn Tg Mice

Presented by Greg Christianson - Senior Scientific Engagement Manager, The Jackson Laboratory

Read Flipbook
about 2 years ago
Potency of PD-1+CTLA-4 Bispecific or Combination in a Humanized Mouse Model

Presented by Richard Stebbings, Ph.D., Senior Director Oncology Safety Science, AstraZeneca

Read Flipbook
about 2 years ago
The Application of Humanized Mouse Models to Study LILRB-Mediated Regulation of Myeloid Cells

Presented by Ali Roghanian, Ph.D., Lecturer (Assistant Professor) in Cancer Immunology & Immunotherapy, University of Southampton

Read Flipbook
about 2 years ago
Validation of hFcRn Transgenic Mice as Powerful Models to Screen Innovative Fc-Engineered Monoclonal and Multi Specific Antibodies

Presented by Delphine Valente, Ph.D., Head of Pharmacokinetics, Modeling and Simulation, DMPK France, Sanofi

Read Flipbook
about 2 years ago
Development of Novel Humanized Mouse Models for Biomedical Research

Presented by Michael Brehm, Ph.D., Associate Professor, Diabetes Center of Excellence Program in Molecular Medicine, University of Massachusetts Chan Medical School

Read Flipbook

Return to Home

© The Jackson Laboratory